Prosecution Insights
Last updated: October 25, 2026

Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner and 1 distinct art unit, which reflects a very concentrated prosecution effort. This singular focus suggests that the company is currently managing a specific pharmaceutical asset through the patent office's examination process.

GREENE, IVAN A is the busiest examiner with 1 pending office action. With only 1 action pending in the entire portfolio, the company's current prosecution is entirely focused on this 1 examiner and art unit. This means that the immediate future of the company's biotechnology patenting efforts rests on the resolution of this 1 pending office action by GREENE, IVAN A within the 1 distinct art unit identified.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GREENE, IVAN A 1 18.8% +6.1%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18710148 A FILM COATED TABLET COMPRISING MICRONIZED TOFACITINIB GREENE, IVAN A —

Top Art Units

Art UnitApps
1619 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18710148 A FILM COATED TABLET COMPRISING MICRONIZED TOFACITINIB GREENE, IVAN A 1619 §102§103§112 Non-Final OA — Pending May 14, 2024

Managing Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi have?

Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi applications?

Ivan A Greene has the most, with 1 of Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi's pending office actions.

What technology area are Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month